G907-0227 Screening compound: 2-[1-({1-[(4-chlorophenyl)methyl]-1H-indol-2-yl}methyl)piperidine-4-carbonyl]-1,2,3,4-tetrahydroisoquinoline

G907-0227 Screening compound: 2-[1-({1-[(4-chlorophenyl)methyl]-1H-indol-2-yl}methyl)piperidine-4-carbonyl]-1,2,3,4-tetrahydroisoquinoline
G907-0227 Screening compound: 2-[1-({1-[(4-chlorophenyl)methyl]-1H-indol-2-yl}methyl)piperidine-4-carbonyl]-1,2,3,4-tetrahydroisoquinoline alternative view

Chemical Structure Depiction of ChemDiv screening compound G907-0227
2-[1-({1-[(4-chlorophenyl)methyl]-1H-indol-2-yl}methyl)piperidine-4-carbonyl]-1,2,3,4-tetrahydroisoquinoline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G907-0227

Molecular Formula

C31H32ClN3O (C31 H32 ClN3 O)

Compound Name

2-[1-({1-[(4-chlorophenyl)methyl]-1H-indol-2-yl}methyl)piperidine-4-carbonyl]-1,2,3,4-tetrahydroisoquinoline

IUPAC name

2-[1-({1-[(4-chlorophenyl)methyl]-1H-indol-2-yl}methyl)piperidine-4-carbonyl]-1234-tetrahydroisoquinoline

SMILES

O=C(C1CCN(Cc2cc(cccc3)c3n2Cc(cc2)ccc2Cl)CC1)N(CC1)Cc2c1cccc2

InChI

InChI=1S/C31H32ClN3O/c32-28-11-9-23(10-12-28)20-35-29(19-26-6-3-4-8-30(26)35)22-33-16-13-25(14-17-33)31(36)34-18-15-24-5-1-2-7-27(24)21-34/h1-12,19,25H,13-18,20-22H2

InChI Key

VCLYOBPNBPKDAU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27167356

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

498.07

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

6.154

Distribution Coefficient, logD

3.880

Water Solubility, LogSw

-6.60

Polar Surface Area

21.216

Acid Dissociation Constant (pKa)

23.09

Base Dissociation Constant (pKb)

9.67

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.30

G907-0227 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

KRAS-Targeted Library (16000 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Hemic and lymphatic
  • Cardiovascular
  • Nervous system
Targets:
  • GPCR
  • Kinases
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G907-0227 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G907-0227?
Check Price and Availability of G907-0227, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G907-0227 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G907-0227
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G907-0227
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G907-0227 available by request